期刊文献+

前列腺炎的MRI及MRS初步研究 被引量:7

The Initial Study of MRI and MRS in Prostatitis
原文传递
导出
摘要 目的研究前列腺炎外周带的MRI表现及MR波谱(MRS)特征。资料与方法 21例前列腺炎患者行MRI平扫加MRS成像,观察前列腺外周带的信号形态及信号强度,同时计算感兴趣区的胆碱(Cho)+肌酸(Cre)/枸橼酸盐(Cit)比值。结果 21例前列腺炎患者平均前列腺特异抗原(PSA)水平是31.80 ng/ml。2例呈非结节局灶低信号,10例显示为双侧外周带弥漫低信号,3例显示为一侧外周带弥漫低信号,1例显示为结节状局灶低信号,其余5例没有信号异常。14例MRS谱线示Cho峰升高,Cit峰下降或消失,另7例MRS谱线正常,21例(Cho+Cre)/Cit均值为6.44。结论前列腺炎外周带低信号(T2WI)对前列腺癌并不具有特异性,前列腺炎的MRS谱线可类似于前列腺癌的波谱特征,可导致前列腺癌的假阳性诊断。 Objective To discuss MRI and MRS features of prostatitis in the peripheral zone.Materials and Methods MR imaging and three-dimensional MR spectroscopic imaging were performed retrospectively in 21 patients.The changes of signal intensity(SI)in the peripheral zone of prostate were observed.On MR spectroscopic imaging,ratio of choline plus creatine to citrate was calculated.Results In the 21 patients,mean pretreatment prostate-specific antigen level was 31.80 ng/ml.2 patients had non-nodular focal low SI,10 patient showed diffuse low SI.3 patient showed diffuse low SI in one side,1 patient showed nodular focal low SI.The remaining 5 patients had no abnormal intensity.14 of 21 patients demonstrated elevated choline peak and citrate peak was reduced or disappeared.In 7 patients,the normal MRS findings were seen.The mean value of Cho+Cre/Cit was 6.44.Conclusion On MR spectroscopic imaging,prostatitis may demonstrate metabolic abnormality that leads to false-positive diagnosis of prostate cancer.The MRI findings in prostatitis are low SI in the peripheral zone,which was not specific for prostate cancer.
出处 《临床放射学杂志》 CSCD 北大核心 2011年第9期1334-1336,共3页 Journal of Clinical Radiology
关键词 前列腺炎 前列腺癌 磁共振成像 磁共振波谱 Prostatitis Prostate cancer Magnetic resonance imaging Magnetic resonance spectroscopy
  • 相关文献

参考文献9

  • 1王继琛,高玉洁,蒋学祥,李松年,刘赓年.前列腺癌的MRI诊断与分期[J].中华放射学杂志,1996,30(11):741-744. 被引量:28
  • 2Jurgen J ,Stijn W ,Tom W. Prostate Cancer Localization with Dynamic Contrast enhanced MR Imaging and Proton MR Spectroscopic Imaging. Radiology ,2006,241:449.
  • 3lkonen S, Kivisaari L, Tervahartiala P, et al. Prostatic MR imaging : accuracy in differentiating cancer from other prostatic disorders. Acta Radiol,2001,42:348.
  • 4王霄英,周良平,丁建平,山刚志,蒋学祥.前列腺癌的MR波谱定量分析:与系统穿刺活检病理对照研究[J].中华放射学杂志,2004,38(3):268-272. 被引量:85
  • 5Engelhard K, I3o[lenbaeh nal intensity HP,Deimling M,et al. Combination of sig- ts of lesions in the peripheral zone of prosrate with MRI and serum PSA level for differentiating benign disease from prostate cancer. Eur Radiol,2000,10:1947.
  • 6王霄英,周良平,丁建平,李飞宇,山刚志,肖江喜,蒋学祥.RS对中国人前列腺癌鉴别诊断标准的初步研究[J].中国医学影像技术,2004,20(8):1150-1153. 被引量:97
  • 7Bennett B, Richardson P, Gardner WJ. Histopathology and cytology of prostatitis. In : Leporand H, Lawson R, eds. Prostate disease. Philadelphia, Pa : Saunders, 1993,399.
  • 8Dave AS, Hricak H, Steven C,et al. Chronic Prostatitis : MR Imaging and ^1H MR Spectroscopic Imaging Findings-initial Observations. Radiology ,2004,231:717.
  • 9Ferdinand A, Marc E, Marinette V, et al. Differentiation of Prostatitis from Prostate Carcinoma Using ^1H MR Spectroscopic Imaging and Dynamic Contrast-Enhanced MRI. Magn Resort Imag, 1999,10:223.

二级参考文献13

  • 1王继琛,高玉洁,蒋学祥,李松年,刘赓年.前列腺癌的MRI诊断与分期[J].中华放射学杂志,1996,30(11):741-744. 被引量:28
  • 2[1]Kurhanewicz J, Vigneron DB, Hricak H, et al. Three-dimensional H-1 MR imaging of the in situ human prostate with high (0.24-0.7 cm3) spatial resolution[J]. Radiology, 1996, 198(3): 795-805.
  • 3[2]Cornud F, Flam T, Chauveinc, et al. Extraprostatic spread of clinically localized prostate cancer: factors predictive of pT3 tumor and of positive endorectal MR imaging examination results[J]. Radiology, 2002, 224(1): 203-210.
  • 4[5]Bartolozzi C, Crocetti L, Menchi I, et al. Endorectal magnetic resonance imaging in local staging of prostate carcinoma[J]. Abdom Imaging, 2001, 26(2): 111-122.
  • 5[6]Lowry M, Liney GP, Turnbull LW, et al. Quantification of citrate concentration in the prostate by proton magnetic spectroscopy: zonal and age-related differences[J]. Magn Reson Med, 1996, 36(3): 252-358.
  • 6[7]Kurhanewicz J, Swanson MG, Wood PJ, et al. Magnetic resonance imaging and spectroscopic imaging: improved patient selection and potential for metabolic intermediate endpoints in prostate cancer chemoprevention trials[J]. Urology, 2001, 57(suppl 4A): 124-128.
  • 7[8]Hahn P, Smith ICP, Leboldus L, et al. The classification of benign and malignant human prostate tissue by multivariate analysis of 1H magnetic resonance spectra[J]. Cancer Research, 1997, 57(6): 3398-3401.
  • 8[9]Schiebler ML, Tomaszewski JE, Bezzi M, et al. Prostatic carcinoma and benign prostatic hyperplasia: correlation of high-resolution MR and histopathologic findings[J]. Radiology, 1989, 172(1): 131-137.
  • 9[10]Muramoto S, Uematsu H, Kimura H, et al. Differential of prostate cancer from benign prostate hypertrophy using dual-echo dynamic contrast MR imaging[J]. Euro J Radio, 2002, 44(1): 52-58.
  • 10Chang Y,Seminars in Ultrasound CT and MR,1988年,9卷,343页

共引文献191

同被引文献51

引证文献7

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部